A novel method for isolation of human lung T cells from lung resection tissue reveals increased expression of GAPDH and CXCR6 by Day, C.E. et al.
Journal of Immunological Methods 342 (2009) 91–97
Contents lists available at ScienceDirect
Journal of Immunological Methods
j ourna l homepage: www.e lsev ie r.com/ locate / j imResearch paper
A novel method for isolation of human lung T cells from lung resection tissue
reveals increased expression of GAPDH and CXCR6
C.E. Day a,⁎, S.D. Zhang b, J. Riley b, T. Gant b, A.J. Wardlawa, C. Guillen a
a Institute for Lung Health, Department of Infection, Immunity and Inﬂammation, University of Leicester, Glenﬁeld Hospital, Leicester LE3 9QP, United Kingdom
b MRC Toxicology Unit, Hodgkin Building, University of Leicester, PO Box 138, Lancaster Road, Leicester LE1 9HN, United Kingdoma r t i c l e i n f oAbbreviations: FBS, Fetal bovine serum; GAPDH
Phosphate Dehydrogenase; RT-PCR, Reverse transcrip
reaction; PI, Propidium Iodide.
⁎ Corresponding author. Tel.: +44 116 250 2766; fax
E-mail address: caroline2day@gmail.com (C.E. Day
0022-1759/© 2008 Elsevier B.V. Open access under CC B
doi:10.1016/j.jim.2008.12.001a b s t r a c tArticle history:
Received 15 October 2008
Received in revised form 1 December 2008
Accepted 3 December 2008
Available online 6 January 2009Lung T lymphocytes are important in pulmonary immunity and inﬂammation. It has been
difﬁcult to study these cells due to contamination with other cell types, mainly alveolar
macrophages. We have developed a novel method for isolating lung T cells from lung resection
tissue, using a combination of approaches. Firstly the lung tissue was ﬁnely chopped and
ﬁltered through a nylon mesh. Lymphocytic cells were enriched by Percoll density
centrifugation and the T cells puriﬁed using human CD3 microbeads, resulting in 90.5%±1.9%
(n=11) pure lymphocytes. The T cell yield from the crude cell preparation was 10.8±2.1% and
viability, calculated using propidium iodide (PI) staining and trypan blue, was typically over
95%. The puriﬁcation process did not affect expression of CD69 or CD103, nor was there a
difference in the proportion of CD4 and CD8 cells between the starting population and the
puriﬁed cells. Microarray analysis and real time RT-PCR revealed upregulation of GAPDH and
CXCR6 of the lung T cells as compared to blood-derived T cells. This technique highly enriches
lung T cells to allow detailed investigation of the biology of these cells.
© 2008 Elsevier B.V. Open access under CC BY license.Keywords:
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The lung has a large mucosal surface area and is constantly
exposed to awide range of airborne antigens. As an important
site of antigen entry, the adult lung is populated by large
numbers of memory Tcells which are thought to be important
in lung host defence (Wardlaw and Hamid, 2002). T cells
mainly reside within the bronchial lamina propria, in the
alveolar walls and the interstitium (Campbell et al., 2001).
There are more T cells in the lung than in the peripheral
circulation and in a normal lung there have been calculated to
be ten times more T cells than neutrophils (Pabst et al., 1987).
Lung T cells are involved in initiating and regulating the
immune response to pathogens, and the importance of lung, Glyceraldehyde 3-
tion polymerase chain
: +44 116 250 2787.
).
Y license.CD4 T cells is demonstrated by the fact that AIDS patients are
very susceptible to pathogens such as Pnemocystis carinii,
which rarely infects individuals with an intact immune
system (Rosen et al., 1985). However, lung T cells are also
involved in inﬂammatory conditions affecting the lung, such
as asthma (Brightling et al., 2002) and sarcoidosis (Inui et al.,
2001). It would therefore be of great interest to characterise
and study human lung T cells ex vivo and in vitro.
So far, it has been difﬁcult to purify lung T cells due to
contamination of other cell types, particularly alveolar
macrophages. Not only are the alveolar macrophages in
abundance, they also complicate the puriﬁcation of T cells
through their ability to ingest particles and adhere to surfaces.
It is therefore difﬁcult to deplete these cells without also
decreasing the yield of lymphocytes. By a combination of
approaches, we have developed a novel method for isolating
human lung T cells from lung resection tissue from patients
undergoing surgery for lung carcinoma. The phenotype of the
puriﬁed cells was characterised with ﬂow cytometry and by
gene expression using gene array and quantitative reverse
transcriptase polymerase chain reaction (RT-PCR).
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2.1. Lung ﬁltrate
Lung resection tissuewas obtained frompatients undergoing
surgery for carcinoma at the Glenﬁeld Hospital in Leicester, UK.
All patients gave written informed consent and the study was
approved by the Leicestershire Research Ethics Committee.
Macroscopically normal tissuewas excised at least 2 cm from the
tumour. The specimens usually weighed between 10 and 40 g.
2.2. Media and reagents
Media: RPMI-1640 (with L-glutamine and 25 mM Hepes)
(Invitrogen, Paisley, UK) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (Sigma, Dorset, UK)
and antibiotics (Sigma). Histopaque 1077 was purchased from
Sigma. The osmolarity of Percoll (Sigma) and media was
adjusted to 285 mOsm with 10× phosphate buffered saline
(PBS) (Invitrogen) or distilled water, respectively. Percoll was
diluted in media to obtain the 40% and 70% Percoll solutions.
2.3. Puriﬁcation protocol
The lung specimenwas placed inmedia andﬁnely chopped
at room temperature using scissors. The cell suspension was
then ﬁltered twice through 100 μm gauze (Fisher Scientiﬁc,
Loughborough, UK). The resulting ﬁltrate was centrifuged for
10 min at +4 °C, 1400 rpm (394 g), after which erythrocytes
were lysed using ice cold distilled water for 30 s. An equal
volume of ice cold 2× PBSwas immediately added and the cells
were washed once. The cell pellet was resuspended in 40%
Percoll, carefully layered onto 70% Percoll and centrifuged at
2000 rpm (804 g), without brake, at +4 °C for 30 min. After
centrifugation, two layers of cells were formed. One upper
layer on top of the gradient, containing mainly macrophages,
and one lower, lymphocyte enriched, layer in the interface
between the two Percoll concentrations. Each layer was
carefully aspirated and washed twice in cold PBS. CD3+ cells
were further puriﬁed by magnetic separation using anti-CD3
conjugated microbeads and LS columns (Miltenyi Biotech,
Surrey UK), according to manufacturer's instructions. Finally,
purity was assessed with Kimura stain. The Kimura counts
were conﬁrmed using Romanowsky stained cytospins. Viabi-
lity was assessed by Trypan blue (Sigma) and propidium
iodide (BD Biosciences, Oxford, UK).
2.4. Flow cytometry
For ﬂow cytometry, the following antibodies were used:
CD103-PE CD69 (Invitrogen), CD4-FITC and CD8-PE (BD) and
secondary FITC-labelled rabbit anti mouse antibody (DAKO
cytomation, Cambridgeshire, UK). FITC-conjugated Annexin V
and propidium iodide (PI) were both from BD. All stained cells
were analysed in a FACSCanto ﬂow cytometer (BD), using
FACSDiva software (BD).
2.5. Microarray
Two puriﬁed lung T cell preparations (83 million cells, 99%
pure and 20 million cells, 97% pure, respectively) were com-pared to two blood T cell samples from healthy donors
(10 million cells, 26 million cells, both N95% pure), which
were isolated using the same puriﬁcation protocol. Total RNA
was extracted using TRIzol Reagent (Invitrogen) according to
the manufacturer's protocol. The lung T cell preparations
yielded 11 μg and 6.7 μg of RNA respectively. From the blood
samples, 8.5 μg and 8.7 μg of RNA was obtained.
Microarray experiments were performed using a 3DNA
Array 350 kit from Genisphere (Hatﬁeld, PA, USA) and
microarray slides constructed in the MRC toxicology unit in
Leicester, as previously described (Turton et al., 2001). The
microarray slides contained 6000 genes from the human
genome. Two samples (2.5 ug each) labelled with two
different ﬂuorescent dyes (eg the blood sample was labelled
with Cy3 dye and the lung sample with Cy5 dye) were
allowed to hybridize with each slide. For each pair of samples,
twomicroarray slides were used with a reverse-labelling (dye
swapping) design. Microarray slides were scanned using an
Axon GenePix 4200A scanner (Axon Instruments, Union City,
CA) to acquire the microarray images which were subse-
quently processed with GenePix Pro 5 (Axon Instruments),
according to the manufacturer's recommended settings. The
median ﬂuorescent intensity of a feature spot on a microarray
slide was used to represent the expression level of the corres-
ponding gene. No background subtraction was taken as more
evidences are suggesting this may be a better choice than
subtracting background. For quality control, spots ﬂagged as
bad (low quality) by the GenePix software automatically,
or manually by experimenter after visual inspection of
the microarray image, were ﬁltered out and excluded from
further analysis, so were the spots that had lower ﬂuorescent
intensity than their surrounding background.
Each microarray was then normalized by globally shifting
the mode of log ratio values to 0, implicitly making the
assumption that on each microarray slide most genes are not
differentially expressed between the two sample channels.
We chose global normalization instead of local normaliza-
tions such as Lowess normalization because we carried out
reverse-labelling of the same pair of samples in our experi-
mental design, and this reverse-labelling procedure was
designed to rectify the dye biases. By averaging the results
from the two dye-swapped slides for the same pair of
samples, we can eliminate the dye biases that may be present.
To identify differentially expressed genes, the averaged
results for each pair of samples of the two dye-swapped
slides were used. All the genes were ﬁrst sorted by the overall
ﬂuorescence intensity in descending order. Only genes with
an average ﬂuorescence intensity of 1000 or higher for at least
one sample were further considered for identiﬁcation of
differential gene expression. These genes were then sorted by
the absolute value of their log ratio in descending order, so
that the genes which were regarded as most differentially
expressed were on top of the ordered list.
2.6. Real time quantitative RT-PCR
To conﬁrm the results obtained in from the microarray
experiments, one of the lung samples used in the microarray
was compared to three blood samples from healthy donors.
Total RNAwas extracted as for themicroarray and treatedwith
DNAse I (Invitrogen). Reverse transcription was performed
Table 1
The list shows the 20 genes which were most differentially expressed in one
of the two microarrays
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according to manufacturer's protocol. Real time quantitative
RT-PCR reactions were performed in a Stratagene MX3000PGene Normalised log2 ratio of median
GAPD 1.74651
LDHA 1.6857
CD44 1.60579
CCL5 1.553
TNF-a 1.46178
HLA-DPB1 1.42163
L-selectin −1.37451
Ch6 1.34392
CREM 1.30224
PLP2 1.29657
ANXA1 1.29571
NR3C2 1.28638
PRG1 1.23003
FYN 1.22298
VIM 1.19836
CXCR6 1.16809
HLA-DRA 1.16795
Upregulation of expression compared to the control is expressed as the
normalised log2 ratio of the median.thermal cycler system (Stratagene, Amsterdam, The Nether-
lands), using Brilliant SYBRGreen Q PCRMastermix (Stratagene)
and the followingprimers: CXCR6: Forward5′-GGCCCACCAGAA
GCA TTT AC-3′, Reverse 5′-TTA AGG CAG GCC CTC AGG-3′;
GAPDH: Forward 5′-AATGGAAATCCCATCACCATCT-3′, Reverse
5′-CGC CCC ACT TGA TTT TGG; 18 s: Forward: 5′-CTT AGA GGG
ACAAGTGGCG-3′, Reverse 5′-ACGCTGAGCCAGTCAGTGTA-3′.
The conditions for the PCR reactions were:
95 °C for 10 min followed by 40 cycles of 94 °C for 15 s,
58 °C for 30 s and 72 °C for 30 s.
2.7. Statistical analysis
Student's t test was used to compare differences between
groups unless where otherwise stated.
3. Results
3.1. Histopaque does not separate lung lymphocytes
from erythrocytes
Histopaque is a polysucrose/sodium diatrizoate gradient
which is designed to purify mononuclear cells from whole
blood, but has also been used for cells suspended in media to
separate granulocytes from mononuclear cells in blood
(Symon et al., 1994). Since the lung ﬁltrate is a complex
mixture of all loose particles from the lung homogenate, we
originally used Histopaque in an attempt to deplete debris,
dead cells and erythrocytes. However, while Histopaque is
effective for puriﬁcation of peripheral blood mononuclearFig. 1. A: Purity of lymphocytic cells (as determined by Kimura stain) at
different stages of the puriﬁcation process. The ﬁltrate contained 28.64±
2.66% lymphocytic cells, which increased to 53.2±4.56% (pb0.0001) after
Percoll gradient and to 90.5±1.91 (p=0.0013, n=11) after puriﬁcation with
microbeads to CD3. B: Representative FACS histograms showing the
expression of CD3, from the top: ﬁltrate, lymphocyte layer after Percoll and
after MACS puriﬁcation.
Fig. 2. Representative Quantitative RT-PCR ampliﬁcation plots of GAPDH (A) and CXCR6 (B). C: GAPDH expression was upregulated 20.5±5.04 times, and CXCR6
expression 39.3±26.9 times, on lung T cells compared to blood T cells (n=3). 18 s rRNA was used as a normalising housekeeping gene.
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lymphocytic cells were found in the cell pellet after centrifu-
gation (data not shown). Therefore, we concluded that
Histopaque was not suitable for enrichment of mononuclear
cells from lung ﬁltrate. Erythrocytes were instead removed
using hypertonic lysis.3.2. Adherence to plastic does not deplete alveolar macrophages
efﬁciently
Since the adherence to plastic in serum free media is
widely used to deplete or enrichmacrophages andmonocytes
(Helinski et al., 1988; Sporn et al., 1990), we initially used this
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ﬁltrate. However, after two 1 h adherence steps at 37 °C, we
found that even though the number of macrophages
decreased to some extent, the purity of lymphocytes did not
increase, due to loss of these cells in the adherence steps (data
not shown). We therefore did not incorporate an adherence
step into our ﬁnal protocol.
3.3. 40/70% Percoll gradient enrich lymphocytes from
lung ﬁltrate
Percoll is a modiﬁed silica gel that separates cells
according to density and has been used to purify cell types
from various tissues such as the liver and the gut (Svensson
et al., 2002; Xu et al., 2002). Based on previous protocols
(Svensson et al., 2002), we therefore used a discontinuous 40/
70% Percoll gradient to separate macrophages from the
lymphocytic cells in the lung ﬁltrate. After centrifugation
two layers were formed: A lower layer between the two
Percoll concentrations which contained an enriched popula-
tion of lymphocytes, whereas most alveolar macrophages and
epithelial cells formed a layer on top of the gradient. The only
cells which were pelleted at the bottom of the tube were
erythrocytes. After Percoll density centrifugation, the purity
of lymphocytic cells (by morphology) increased from 28.63+/
−12.5% to 53.14±21.5% (n=22) (Fig. 1A). Flow cytometry
analysis also showed a progressive increase in the percentage
of CD3+ cells (Fig. 1B).
3.4. High purity and good yield of lung T cells using CD3 labelled
microbeads
To isolate T cells from the lymphocyte enriched cell pre-
paration, we used CD3-conjugated MACS beads, which
puriﬁed the cells to 90.5±1.9% (n=11) (Fig. 1A). Previous
puriﬁcation with Percoll was required to decrease the
contamination by alveolar macrophages, which otherwise
block the columns. Using a more pure preparation for
immunomagnetic separation also minimises the amount of
beads needed, since this is calculated on the total number of
cells. The yield, calculated as the number of puriﬁed CD3+ cells
divided by the number of lymphocytic cells in the ﬁltrate, was
10.8±2.1 (n=33) %. This ﬁgure is an underestimate, since the
CD3+ cells only constitute approximately 60.62±3.6% (n=25)
of all lymphocytic cells.
3.5. Phenotyping of puriﬁed lung T cells
The viability of the puriﬁed cells as determined by trypan
blue and PI staining was typically over 95%. Staining the cells
with FITC-conjugated Annexin V, which detects early apop-
tosis, showed that 18.53±4.1% (n=6) of the cells were
apoptotic after puriﬁcation. Before puriﬁcation, 5.54±0.97%
(n=4) of the cells bound Annexin V, which shows that
apoptotic cells were already present in the cell preparation
before the puriﬁcation began although there was a modest
increase in apoptosis as part of the puriﬁcation procedure.
The puriﬁed lung T cells were phenotyped using ﬂow
cytometry to demonstrate that the puriﬁcation did not alter
the expression of activation markers or selected for certain T
cell subsets. There was no difference in the ratio of CD8 andCD4 cells before and after puriﬁcation (CD8:CD4 ratio was
1.298±0.43 and 1.088±0.24, respectively, p=0.62, n=5),
neither did the puriﬁcation process affect the expression of
CD103 (36.78±14.2% before puriﬁcation and 27.50±9.10%
after puriﬁcation, p=0.29, n=5) or CD69 (59.50±15.9% before
puriﬁcation, 53.84±13.1% after puriﬁcation, p=0.49, n=5).
In order to determine if the enriched lung T cells could be
used to investigate their phenotype the gene expression
proﬁle of lung to blood CD3+ cells was compared using
microarray. The 20 most up- or downregulated genes from
one experiment are shown in Table 1. Gene expression from a
second patient demonstrated a similar pattern. In both arrays
the gene which was most upregulated in the lung T cells
compared to the blood T cells was Glyceraldehyde 3-
Phosphate Dehydrogenase (GAPDH). This result was con-
ﬁrmed using Quantitative RT-PCR, which demonstrated a
20.5±5.04 times upregulation of GAPDH on lung T cells
compared to blood T cells, whereas 18 s rRNA was expressed
at very similar levels in the two cell types (Fig. 2). The
upregulated genes also included CXCR6 which we have
previously shown to be increased on lung compared to
blood T cells, and L-selectin which is not expressed by lung T
cells. We conﬁrmed increased expression of CXCR6 using
quantitative RT-PCR, which demonstrated a 39.3±26.9 fold
upregulation of CXCR6 on lung T cells compared to blood T
cells (Fig. 2).
4. Discussion
The lung is amajor portal of entry both for non-pathogenic
antigenic material as well as a range of viral and bacterial
pathogens. It therefore has a sophisticated immune system
which involves barrier, innate and speciﬁc immune compo-
nents. Investigation of lung T cells which make up an
important part of lung immunity has been hampered by the
difﬁculty in obtaining large numbers of relatively pure lung T
cells.
As far aswe are aware this is the ﬁrst report that has focused
on the puriﬁcation of lymphocytes from human lung. In this
paper we report a method that has allowed us to routinely
obtain sufﬁcient numbers of viable enriched lung-derived CD3
cells to undertake a detailed examination of their phenotype
both by ﬂow cytometry and gene expression.
Our source of lung T cells was resection tissue. Fine
mincing of resected lung tissue results in the ‘falling out’ of
large numbers of cells (mainly AM but with some lympho-
cytes and granulocytes). Enzymatically digestion of lung
tissue (collagenase and hyaluronidase) released more lym-
phocytes from the lung tissue, but these cells were shown to
have lost expression of certain chemokine receptors (data not
shown). We can obtain about 107 cells in total/gram of tissue
from minced lung tissue although there is considerable
variability in both the total number of cells and the percent-
age of lymphocytes depending on quality of the lung tissue.
The receptor phenotype of these lung-derived T cells strongly
suggests that they are resident in the lung tissue and not from
the circulation as they are quite different from blood T cells in
their expression of activation markers and have a similar
proﬁle of chemokine, adhesion and activation receptors to
bronchoalveolar derived T cells (Campbell et al., 2001;
Morgan et al., 2008). Lung T cells are found in a number of
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by BAL, the bronchial epithelium and submucosa sampled by
biopsy and the lung interstitium. The differences between the
T cell phenotype in these compartments are not known
although the similarities in receptor phenotype between BAL
and lung resection derived cells are striking. Resection T cells
are from the periphery of the lung and likely to be derived
mainly from the interstitium. However there is no reasonwhy
our approach could not be used on BAL T cells although the
number of cells obtained would be considerably less. The
major problem with obtaining lung T cells has been the
abundance of alveolar macrophages. Traditionally adherence
to plastic has been used to deplete macrophage/monocyte
populations but we found that equal numbers of lymphocytes
adhered to the plates possibly due to the increased adhesion
of lung compared to blood lymphocytes so that this step did
not enrich the lymphocytes and we abandoned it. The lung
ﬁltrate contains a considerable amount of debris and we
thought that a Histopaque step would remove red cells and
debris. However this step resulted in loss of T cells and was
also abandoned. We have in contrast found a discontinuous
40/70% Percoll gradient to be a reliable way to enrich the
lymphocyte population. This allowed us to further enrich
T cells using positive selection with immunomagnetic
separation, which is a versatile approach as we could also
enrich for other lymphocytic subsets if required. According to
the manufacturer, the magnetic sorting does not result in
downstream signalling or activation of the T cells. We did not
detect down-regulation of CD3 after separation, as seen after
activation with CD3/CD28 activating beads (data not shown).
The contaminating cells were mainly macrophages and if
even greater purity was required an alternative would be to
try and remove these by another method such as phagocy-
tosis of iron ﬁlings. In microarray and PCR experiments, N95%
pure T cell preparations were used.
With any puriﬁcation procedure there is the concern that
one subset is being preferentially enriched. However at least
in terms of CD4/CD8 and activation markers there was no
difference in the starting versus the puriﬁed population. The
lack of difference in CD69 expression which is rapidly
upregulated with T cell activation also is some reassurance
that the positive selection using an anti-CD3 antibody didn't
activate the cells.
One of the aims of obtaining an enriched lung T cell
population is to be able to do experiments which would not
be possiblewith a ﬁltrate sample. Flow cytometry can be done
on unpuriﬁed lung T cells (although gating difﬁculties and
background mean that this is not trivial) however studies
involving gene expression need nearly pure populations. As a
proof of concept that our methods resulted in a useful
population of T cells we studied differences between
unstimulated peripheral blood CD3 cells (enriched in iden-
tical fashion to the lung T cells) and the lung T cells using a
customised gene array platform with a gene chip that
contains only 6000 genes enriched for immune regulatory
genes andmost of the chemokine receptorsWewere gratiﬁed
to observe that the differences in gene expression made sense
in terms of what we know about the differences in receptor
expression between the two populations. In particular we
have previously shown that of all the chemokine receptors
CXCR6 showed the most difference in expression betweenlung and blood T cells (Morgan et al., 2005). In the gene array
it was striking that CXCR6 was the only chemokine receptor
that showed up as being enriched on lung T cells and further
supports the idea that this is a key receptor involved in
constitutivemigration of Tcells to the lung.We conﬁrmed this
observation by quantitative RT-PCR on T cells from other
donors. To our surprise the gene that came up as showing the
most difference in gene expression was GAPDH, which is one
of the key enzymes in glycolysis. We also conﬁrmed increased
expression by RT-PCR. GAPDH is often used as a housekeeping
gene since it is constitutively expressed in most cell types.
However, it has previously been shown that GAPDH is
upregulated after activation in peripheral blood mononuclear
cells and intestinal lymphocytes (Bas et al., 2004). Our results
also suggest an upregulation of GAPDH in the lung T cells
compared to the naive blood T cell. The mechanism for this
and what it means in terms of the function of lung T cells
remains to be investigated but it does suggest that GAPDH is
not suitable as a house keeping gene for normalisation of
mRNA expression levels in cells with different activation
status. We did not compare blood and lung T cells from the
same donor because of the logistical and ethical problems in
obtaining blood from the patients undergoing surgery. The
lung T cells were from patients undergoing lung resection
whereas the blood T cells were from normal donors. We
cannot exclude the possibility that our ﬁndings with GAPDH
were not due to this difference although as the tissue was
taken from relatively normal lung and the subjects were in
good health with early stage lung cancer we feel it is unlikely.
We have previously noted enriched CXCR6 expression on lung
compared to blood T cells in matched donors so we think that
this difference was undoubtedly independent of any donor
effect. We therefore feel that the gene expression experi-
ments have shown proof of principle that lung T cells puriﬁed
according to the described method can be used to learn more
about the function of these cells as well as raising intriguing
questions about the glycolytic pathway in lung T cells and
how this might relate to their function.
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